|20 Oct 2023
|BAL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 ,inter alia, to consider and approve 1. Unaudited financial results for the quarter and half year ended 30.09.2023. 2.Allotment of equity shares to the employees of the Company who has exercised the conversion option on employee stock options vested on them. 3. To grant stock options under Bal Pharma Ltd-Employee stock option scheme 2014 , to the eligible employees of the Company.
|View all announcements for BAL PHARMA LTD.
|Source: BSE India